SLC7A7 and plasma cell myeloma: Notably, the analysis revealed that SLC7A7 expression was significantly correlated with prognosis in six types of cancer, including multiple myeloma, prostate, colorectal, glioma, breast and lung cancer (Fig. 3a–h).